AVILAR THERAPEUTICS

avilar-therapeutics-logo

Avilar Therapeutics is a biopharmaceutical company focusing on the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation.

#SimilarOrganizations #People #Financial #Event #Website #More

AVILAR THERAPEUTICS

Social Links:

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2020-01-01

Address:
Waltham, Massachusetts, United States

Country:
United States

Website Url:
http://www.avilar-tx.com

Total Employee:
11+

Status:
Active

Total Funding:
75 M USD

Technology used in webpage:
Google Maps Google Google Cloud


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

autolus-logo

Autolus

Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

eikon-therapeutics-logo

Eikon Therapeutics

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

lucaspye-bio-logo

LucasPye BIO

A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

tcr2-logo

TCR2

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.

trevarx-biomedical-logo

Trevarx Biomedical

Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.


Current Advisors List

not_available_image

Tess Cameron Board Member @ Avilar Therapeutics
Board_member
2020-10-01

josh-resnick_image

Josh Resnick Board Member @ Avilar Therapeutics
Board_member
2021-11-01

paulina-hill_image

Paulina Hill Board Member @ Avilar Therapeutics
Board_member
2023-02-16

Current Employees Featured

not_available_image

Effie Tozzo
Effie Tozzo Chief Scientific Officer @ Avilar Therapeutics
Chief Scientific Officer
2021-11-01

daniel-grau_image

Daniel Grau
Daniel Grau Founder, CEO & President @ Avilar Therapeutics
Founder, CEO & President

adam-muzikant_image

Adam Muzikant
Adam Muzikant Chief Business Officer @ Avilar Therapeutics
Chief Business Officer
2022-06-01

not_available_image

Phil Graham
Phil Graham SVP, Chief Development Officer @ Avilar Therapeutics
SVP, Chief Development Officer
2021-06-01

Founder


daniel-grau_image

Daniel Grau

milind-deshpande_image

Milind Deshpande

Investors List

medical-excellence-capital_image

Medical Excellence Capital

Medical Excellence Capital investment in Seed Round - Avilar Therapeutics

astellas-venture-management_image

Astellas Venture Management

Astellas Venture Management investment in Seed Round - Avilar Therapeutics

sanofi-genzyme-bioventures_image

Sanofi Ventures

Sanofi Ventures investment in Seed Round - Avilar Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Seed Round - Avilar Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Seed Round - Avilar Therapeutics

Key Employee Changes

Date New article
2022-06-15 Avilar Therapeutics Appoints Adam Muzikant, PhD, as Chief Business Officer

Official Site Inspections

http://www.avilar-tx.com Semrush global rank: 7.36 M Semrush visits lastest month: 804

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Avilar Therapeutics"

About Us - Avilar Therapeutics

At Avilar, we are moving beyond the boundaries of the cell to pioneer the discovery and development of extracellular protein degraders.See details»

Team - Avilar Therapeutics

Rene Lemieux, PhD SVP and Head of Drug Discovery SciencesSee details»

Avilar Therapeutics - LinkedIn

Avilar Therapeutics is a biopharmaceutical company pioneering the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation.See details»

Avilar Therapeutics - Crunchbase Company Profile

Avilar Therapeutics is a biopharmaceutical company focusing on the discovery and development of extracellular protein degraders, a new frontier in targeted …See details»

Avilar Therapeutics 2025 Company Profile: Valuation, …

Information on valuation, funding, cap tables, investors, and executives for Avilar Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

Avilar Therapeutics Org Chart + Executive Team - The Official Board

The org chart of Avilar Therapeutics contains its 18 main executives including Daniel Gau, Effie Tozzo and Paul Muir.See details»

Avilar Therapeutics, Inc. (Avilar Therapeutics, Inc.) - 药物管线_专利_ …

Avilar has built a proprietary discovery platform that includes novel, high-affinity, small molecule ASGPR (asialoglycoprotein receptor) ligands and advanced modeling of the biophysics, …See details»

Avilar Therapeutics, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Avilar Therapeutics, Inc. of Newton, MA. Get the latest business insights from Dun & Bradstreet.See details»

Avilar Therapeutics Increases Financing to $75 Million to Advance ...

In addition, the funding will be used to grow the company and expand the Avilar platform of proprietary technologies, all custom-built and tailored to designing and building extracellular …See details»

Avilar Therapeutics - VentureRadar

"Avilar Therapeutics is a biotech company developing ATACs (ASGPR Targeting Chimeras), a novel class of degrader designed to harness a natural endogenous process for protein …See details»

Avilar Therapeutics Increases Financing to $75 Million to Advance ...

Feb 16, 2023 Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced it has raised additional funding with an expanded syndicate of …See details»

Avilar - Products, Competitors, Financials, Employees, …

About Avilar Avilar Therapeutics is a biopharmaceutical company focused on the discovery and development of novel protein degraders within the healthcare sector. The company's main …See details»

Avilar Therapeutics - LifeScienceHistory.com

Avilar Therapeutics is a biopharmaceutical company pioneering the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation.See details»

About - Avilar Therapeutics

© 2025 Avilar Therapeutics, Inc.PrivacySee details»

Avilar Therapeutics

Avilar Therapeutics is developing methods to degrade extracellular proteins. More than 35% of human proteins are located outside the cell and many have a clearly defined role in the …See details»

Avilar - 2025 Company Profile, Funding & Competitors - Tracxn

Mar 28, 2025 Avilar is a seed company based in Waltham (United States), founded in 2020 by Milind Deshpande and James Kasuboski. It operates as a Provider of drug discovery platform …See details»

Avilar Therapeutics Increases Financing to $75 Million to Advance ...

Feb 16, 2023 Avilar is leveraging its ATAC platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. Avilar is based in Waltham, MA.See details»

Avilar Competency Model | Avilar Competency Management

The Avilar Competency Model was developed from decades of work with organizations of all types and sizes. It contains over 350 skills clustered into more than 50 skill groups. Our …See details»

Core Values - Avilar Therapeutics

Everyone at Avilar has the audacity to believe that by radically and rapidly innovating together we will fundamentally transform the lives of patients.See details»

linkstock.net © 2022. All rights reserved